HuGE Literature Finder
Records 1-30
|
Comprehensive genomic profile of Chinese lung cancer patients and mutation characteristics of individuals resistant to icotinib/gefitinib.
Scientific reports 2020 Nov 10 (1): 20243. Shang Yanhong, Li Xiaofang, Liu Weiwei, Shi Xiaoliang, Yuan Shaohua, Huo Ran, Fang Guotao, Han Xiao, Zhang Jingnan, Wang Kunjie, Dou Zhengyue, Zhang Yan, Zang Aimin, Zhang L |
|
EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell cancer in South India.
Cancer reports (Hoboken, N.J.) 2020 Sep e1288. Tarigopula Anil, Ramasubban Gayathri, Chandrashekar Vani, Govindasami Perumal, Chandran Chit |
|
Different driver gene mutations in patients with synchronous multiple primary lung cancers: a case report.
Journal of cardiothoracic surgery 2020 Jul 15 (1): 196. Yang Yong, Xie Xiaofeng, Jiang Gening, Liu Hongche |
|
Genetic profile of non-small cell lung cancer (NSCLC): A hospital-based survey in Jinhua.
Molecular genetics & genomic medicine 2020 Jul e1398. Chen Xianguo, Xu Bo, Li Qiang, Xu Xiaoyi, Li Xianshuai, You Xia, Yu Zhaon |
|
Non-small cell lung cancer in the very young: Higher EGFR/ALK mutation proportion than the elder.
Journal of the Chinese Medical Association : JCMA 2020 Mar . He Chien-Hui, Shih Jen-Fu, Lai Shinn-Liang, Chen Yuh-M |
|
Expression Profiling of Driver Genes in Female Never-smokers With Non-adenocarcinoma Non-small-cell Lung Cancer in China.
Clinical lung cancer 2020 Feb . Zhao Yiming, Dong Yu, Zhao Ruiying, Zhang Bo, Wang Shuyuan, Zhang Lele, Hu Minjuan, He Qingnan, Zhang Wei, Han Baoh |
|
Identification of germline and somatic mutations in pancreatic adenosquamous carcinoma using whole exome sequencing.
Cancer biomarkers : section A of Disease markers 2020 Jan . Ma Hongyun, Song Bin, Guo Shiwei, Li Gang, Jin Ga |
|
EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer.
Virchows Archiv : an international journal of pathology 2019 Dec . Satoh Yukitoshi, Matsuo Yukiko, Kuba Tatsuru, Yamashita Kazuya, Sawano Mariko, Tozaka Shusaku, Yamazaki Hirotsugu, Sonoda Dai, Mikubo Masashi, Naito Masahito, Matsui Yoshio, Shiomi Kazu, Yoshida Tsutomu, Murakumo Yoshi |
|
Regional distribution of genetic mutation in lung cancer in Turkey (REDIGMA).
Tuberkuloz ve toraks 2019 Sep 67 (3): 197-204. Özçelik Neslihan, Aksel Nimet, Bülbül Yilmaz, Erdogan Yurdanur, Güldaval Filiz, Karabulut Gül Sule, Bircan Ahmet, Can Atilla, Öz Necdet, Sentürk Aysegül, Arinç Sibel, Kiliç Talat, Kurt Emine Bahar, Günay Ersin, Çaglayan Benan, Çelebi Aydin Derya, Basyigit Ilknur, Savas Ismail, Tatar Dursun, Arslan Sulhattin, Kömürcüoglu Berna, Bayram Mehmet, Gülmez Inci, Dogan Ömer Tamer, Özgün Niksarlioglu Elif Yelda, Kaba Erkan, Karaoglanoglu Selen, Aydin Özgür Esra, Özçelik Ali Erdem, Özlü Tevfik, |
|
Analysis of the genomic landscape in ALK+ NSCLC patients identifies novel aberrations associated with clinical outcomes.
Molecular cancer therapeutics 2019 Jun . Couetoux du Tertre Mathilde, Marques Maud, Tremblay Lise, Bouchard Nicole, Diaconescu Razvan, Blais Normand, Couture Christian, Pelsser Vincent, Wang Hangjun, Higenell Valerie, Izzi Luisa, Gambaro Karen, Hoffert Cyrla, Srivastava Archana, Spatz Alan, Rousseau Caroline, McNamara Suzan, Cohen Victor, Batist Gerald, Agulnik Jas |
|
Molecular Testing for EGFR Mutations and ALK Rearrangements in the Cytological Specimens From the Patients With Non-Small Cell Lung Cancer.
Applied immunohistochemistry & molecular morphology : AIMM 2019 Jan . Wang Xiaoyan, Chen Shaoxiong, Emerson Robert E, Wu Howard H, Cramer Harvey M, Curless Kendra, Chang Hsim Yee, Zhang Shaobo, Randolph Melissa L, Cheng Lia |
|
Prevalence of
Journal of cancer research and therapeutics 2019 15 (4): 909-913. Yu Yongfeng, Zhang Qing, Zhang Jie, Lu Sh |
|
Molecular Genetic Alterations in Thyroid Transcription Factor 1-Negative Lung Adenocarcinoma in Cytology Specimens: A Subset With Aggressive Behavior and a Poor Prognosis.
Cancer cytopathology 2018 Sep . Rodriguez Erika F, VandenBussche Christopher J, Chowsilpa Sayanan, Maleki Zah |
|
[Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases].
Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 Jun 47 (6): 432-437. Fang F, Wang Y X, Hu S T, Yang L, Di J, Liu D G, Lyu |
|
A study of therapy targeted EGFR/ALK mutations in Indian patients with lung adenocarcinoma: A clinical and epidemiological study.
Medical journal, Armed Forces India 2018 Apr 74 (2): 148-153. Rana Vandana, Ranjan Praveer, Jagani Rajat, Rathi K R, Kumar Dharmesh, Khera Anur |
|
Frequent genomic alterations and better prognosis among young patients with non-small-cell lung cancer aged 40 years or younger.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2018 Feb . Pan X, Lv T, Zhang F, Fan H, Liu H, Song |
|
Distinct clinicopathologic features, genomic characteristics and survival of central and peripheral pulmonary large cell neuroendocrine carcinoma: From different origin cells?
Lung cancer (Amsterdam, Netherlands) 2018 02 116 30-37. Zhou Fei, Hou Likun, Ding Ting, Song Quanming, Chen Xiaoxia, Su Chunxia, Li Wei, Gao Guanghui, Ren Shengxiang, Wu Fengying, Fan Jiang, Wu Chunyan, Zhang Jie, Zhou Caic |
|
Identification of a Novel BRAF Thr599dup Mutation in Lung Adenocarcinoma.
Open medicine (Warsaw, Poland) 2018 13 278-280. Zhang Xuefei, Li Mo, Lv Desheng, Sun Ge, Bai Yu, Tian Hui, Liu Changho |
|
Comprehensive genomic profiling of lung cancer using a validated panel to explore therapeutic targets in East Asian patients.
Cancer science 2017 Dec 108 (12): 2487-2494. Liu Liping, Liu Jilong, Shao Di, Deng Qiuhua, Tang Hailing, Liu Zu, Chen Xuewei, Guo Fengming, Lin Yongping, Mao Mao, Kristiansen Karsten, Ye Mingzhi, He Jianxi |
|
Mutational Diversity of Lung Cancer and Associated Lymph Nodes. An Exploratory Prospective Study of 4 Resected cIIIA-N2.
Pathology oncology research : POR 2017 Nov . Legras Antoine, Roussel Hélène, Mangiameli Giuseppe, Arame Alex, Grand Bertrand, Pricopi Ciprian, Badia Alain, Gibault Laure, Badoual Cécile, Fabre Elizabeth, Laurent-Puig Pierre, Blons Hélène, Le Pimpec-Barthes Françoi |
|
[Clinical significance and mechanism of upregulation of PI3Kp110? in non-small cell lung carcinoma].
Zhonghua zhong liu za zhi [Chinese journal of oncology] 2017 Oct 39 (10): 737-743. Xiong Y, Qu L L, Li D, Wang Y, Li |
|
Oncogenic driver mutations, treatment, and EGFR-TKI resistance in a Caucasian population with non-small cell lung cancer: survival in clinical practice.
Oncotarget 2017 Sep 8 (44): 77897-77914. Faehling Martin, Schwenk Birgit, Kramberg Sebastian, Eckert Robert, Volckmar Anna-Lena, Stenzinger Albrecht, Sträter Jö |
|
Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patients.
Pathology 2017 Aug . Russell Prudence A, Rogers Toni-Maree, Solomon Benjamin, Alam Naveed, Barnett Stephen A, Rathi Vivek, Williams Richard A, Wright Gavin M, Conron Matth |
|
Immunological Status May Predict Response to Nivolumab in Non-small Cell Lung Cancer without Driver Mutations.
Anticancer research 2017 Jul 37 (7): 3781-3786. Nakao Makoto, Muramatsu Hideki, Kagawa Yusuke, Suzuki Yuto, Sakai Yusuke, Kurokawa Ryota, Fujita Kohei, Sato Hidefu |
|
Relationship between driver gene mutations, their relative protein expressions and survival in non-small cell lung carcinoma in Macao.
The clinical respiratory journal 2017 Jul . Chan Kin Iong, Vong Hong Ting, Sin Lai Fang, Yip Yuk Ching, Zhong Xue Yun, Wen Jian Mi |
|
MET exon 14 skipping mutation in triple-negative pulmonary adenocarcinomas and pleomorphic carcinomas: An analysis of intratumoral MET status heterogeneity and clinicopathological characteristics.
Lung cancer (Amsterdam, Netherlands) 2017 Apr 106 131-137. Kwon Dohee, Koh Jaemoon, Kim Sehui, Go Heounjeong, Kim Young A, Keam Bhumsuk, Kim Tae Min, Kim Dong-Wan, Jeon Yoon Kyung, Chung Doo Hy |
|
Comprehensive profiling and quantitation of oncogenic mutations in non-small cell lung carcinoma using single-molecule amplification and re-sequencing technology.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2017 Feb 39 (2): 1010428317691413. Shi Jian, Yuan Meng, Wang Zhan-Dong, Xu Xiao-Li, Hong Lei, Sun Shengl |
|
Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions.
The oncologist 2017 Feb . Vanden Borre Pierre, Schrock Alexa B, Anderson Peter M, Morris John C, Heilmann Andreas M, Holmes Oliver, Wang Kai, Johnson Adrienne, Waguespack Steven G, Ou Sai-Hong Ignatius, Khan Saad, Fung Kar-Ming, Stephens Philip J, Erlich Rachel L, Miller Vincent A, Ross Jeffrey S, Ali Siraj |
|
A comprehensive analysis of clinical outcomes in lung cancer patients harboring a MET exon 14 skipping mutation compared to other driver mutations in an East Asian population.
Lung cancer (Amsterdam, Netherlands) 2017 Jan 103 82-89. Gow Chien-Hung, Hsieh Min-Shu, Wu Shang-Gin, Shih Jin-Yu |
|
EML4-ALK-negative mucinous bronchioalveolar/adenocarcinoma (BAC/AC) of the lung in a 15-year-old female patient with CPAM.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): e21007. Abdolmohammadi A, Fallat M E, Balasa V V, Kloecker G |
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 04, 2020
- Content source: